Skin permeation and transdermal delivery systems of drugs: History to overcome barrier function in the stratum corneum

Yakugaku Zasshi

Volumn 129, Issue 12, 2009, Pages 1453-1458

  Sugino, Masahiro ^a   Todo, Hiroaki ^a   Sugibayashi, Kenji ^a  

^a JOSAI UNIVERSITY   (Japan)

Author keywords

Chemical enhancer; Physical enhancer; Stratum corneum; Transdermal drug delivery system

Indexed keywords

ADRENALIN; ALCOHOL; CLONIDINE; DICLOFENAC; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORELGESTROMIN; FATTY ACID ESTER; FENTANYL; GLYCERYL TRINITRATE; IONTOCAINE; LIDOCAINE; LIDOSITE; METHYLPHENIDATE; NICOTINE; OXYBUTYNIN; PRODRUG; RIVASTIGMINE; ROTIGOTINE; SCOPOLAMINE; SELEGILINE; TERPENE; TESTOSTERONE; UNCLASSIFIED DRUG;

CHEMICAL MODIFICATION; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; ELECTRIC ACTIVITY; ELECTROPORATION; ENERGY; FIBROBLAST; HUMAN; KERATINOCYTE; NEEDLE; SKIN CULTURE; SKIN FUNCTION; SKIN PENETRATION; STRATUM CORNEUM; THERMAL CONDUCTIVITY; TISSUE ENGINEERING; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; DOSAGE FORMS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; PERMEABILITY; SKIN; SKIN ABSORPTION; TECHNOLOGY, PHARMACEUTICAL;

EID: 73449141129     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.129.1453     Document Type: Conference Paper

References (14)

1. Sato K., Sugibayashi K., Morimoto Y., Omiya H., Enomoto N., J. Pharm. Pharmacol., 41, 379-383 (1989).
2. Chattaraj S. C., Walker R. B., "Percutaneous Penetration Enhancer," eds. by Smith E. W., Maibach H. I., CRS Press, New York, 1995, pp. 5-20.
3. Singh P., Liu P., "Topical Absorption of Dermatological Products,"' eds. by Bronaugh R. L., Maibach H. I., Marcel Dekker, Inc., New York, 2002, pp. 353-376.
4. Mori K., Hasegawa T., Sato S., Sugibayashi K., J. Control. Release, 90, 171-179 (2003).
5. Kost J., Mitragotri S., Langer R., "Topical Absorption of Dermatological Products," eds. by Bronaugh R. L., Maibach H. I., Marcel Dekker, Inc., New York, 2002, pp. 335-351.
6. Ueda H., Sugibayashi K., Morimoto Y., J. Control. Release, 37, 291-297 (1995).
7. Bellhouse B. J., Kendall M. A. F., "Modified-Release Drug Delivery Technology," eds. by Rathbone M. J., Hadgraft J., Roberts M. S., Marcel Dekker, Inc., New York, 2003, pp. 607-617.
8. Benson H. A., Namjoshi S., J. Pharm. Sci., 97, 3591-3610 (2008).
9. 〈http://www.accessdata.fda.gov/Scripts/cder/Drugsatfda/〉
10. Guy R. H., Drug Delivery System, 22, 442-449 (2007).
11. Prausnitz M. R., Mitragotri S., Langer R., Nat. Rev. Drug Discov., 3, 115-124 (2004).
12. Bell E., Ehrlich H. P., Buttle D. J., Nakatshji T., Science, 211, 1052-1054 (1981).
13. Hada N., Hasegawa T., Takahashi H., Ishibashi T., Sugibayashi K., J. Control. Release, 108, 341-350 (2005).
14. Hada N., Todo H., Komada F., Sugibayashi K., Pharm. Res., 24, 1473-1479 (2007).